PDCD1 and head and neck squamous cell carcinoma: For LA-HNSCC patients, JAVELIN head and neck 100 trial [22, 23]and KEYNOTE-412 [24] study aimed to explore the efficacy and safety for survival outcome in PD-L1 or PD-1 inhibitors combined with chemoradiotherapy, however both trials got the negative results.